Authors/Disclosures
|
Gregory J. O'Shanick, MD
(Center for Neurorehabilitation Services)
|
No disclosure on file |
|
Hubert H. Fernandez, MD, FAAN
(Center for Neurological Restoration, Cleveland Clinic)
|
Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group. |
|
Stephen Page, PhD
(University of Cincinnati)
|
No disclosure on file |
|
|
No disclosure on file |
|
Jack S. Burks, MD, FAAN
(Burks & Associates)
|
No disclosure on file |
|
Andrea Formella, PharmD, BCPP
(Supernus Pharmaceuticals)
|
Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc.. |
|
Francesca Baldinetti, MD
(Genzyme, a Sanofi Company)
|
No disclosure on file |